EP Patent

EP2477634A1 — Non-sedating antihistamine injection formulations and methods of use thereof

Assigned to JDP Therapeutics Inc · Expires 2012-07-25 · 14y expired

What this patent protects

Disclosed are injectable formulations of cetirizine for treating acute allergic reactions and methods for treating acute allergic reactions. In particular, an intravenous injectable is disclosed as are methods of treating acute allergic reactions therewith.

USPTO Abstract

Disclosed are injectable formulations of cetirizine for treating acute allergic reactions and methods for treating acute allergic reactions. In particular, an intravenous injectable is disclosed as are methods of treating acute allergic reactions therewith.

Drugs covered by this patent

Patent Metadata

Patent number
EP2477634A1
Jurisdiction
EP
Classification
—
Expires
2012-07-25
Drug substance claim
No
Drug product claim
No
Assignee
JDP Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.